Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years
Clinical trial NCT01035749 · COMPLETED
Trial details
- NCT number
- NCT01035749
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-09-27
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.